Boehringer Ingelheim
Flomax Case Study
Evolving Disease State Awareness to Succeed with New Method of Action
| Publication Date | July 2008 |
| Publisher | Best Practices LLC |
| Product Type | Report |
| Pages | 54 |
| ISBN Number | not applicable |
| Product Code | BPC00014 |
Summary
This case study reviews the strategy and tactics utilized by Boehringer-Ingelheim for the BPH (Benign Prostatic Hyperplasia) indicated product, Flomax/Tamsulosin, to differentiate the product and to boost disease awareness to expand the product market. By carving out a niche as a BPH-specific drug and motivating a large untapped patient pool through multiple communication tactics, Flomax achieved blockbuster status. Executives and managers can use this research to gain insights into methods for differentiating a product and creating effective communication tactics to boost awareness and sales of a new product.
Contents
- Executive Summary
- Rationale for Alpha1 Blocker/Flomax Analog
- Flomax Market Entry
- Findings: Flomax Market-Entry Insights Are Broad Reaching
- Flomax Commercialization Timeline
- Market Entry Strategy
- Market Entry Strategies Cover Basics plus Personalize Condition
- Leading with Science
- Anchor Brand Positioning in Science, Safety & Unmet Need
- Build upon The Scientific Edifices That Precede Your Drug
- Earlier Achievements Can Help Catapult The New Product
- to Market Leadership
- Use New Science to Break Old Paradigms
- Product Positioning
- Position The New Product to Reflect Total Cost Benefits
- First Approved Alpha Blocker Positioned as Less Risky
- Differentiate through Improved Mechanism of Action
- Develop Compelling Brand Promise around New Benefit
- Extend Sales & Marketing Reach & Expertise with Partnerships
- Disease Awareness
- Leverage Market Research to Motivate Untreated Patients
- Early Successive Generation Must Hit A Higher Standard
- Use Multiple Communication Channels to Prepare Medical Market
- Let Kols Lead The Way to A New Paradigm
- Expand & Vary Key Messages to Physicians over Time
- Segment Physician Message to Drive Brand Momentum
- Expedite Change by Providing Useful Diagnostic Tools
- Use Professional Guidelines to Elevate Drug's Role in Treatment
- Patient Communications
- Motivate Men to Seek ""one Week"" Improvement in Quality of Life
- Target Patient's Family to Accelerate Treatment Pathway
- Websites Are An Essential Tool in Patient & Family Education
- Provide Communication Tools to Facilitate Patient Conversations
- Overall Market Outreach
- Use Dtc to Build Awareness, Complement Professional Campaign
- A Celebrity Spokesperson Can Help Personalize & Educate
- Support Advocacy Groups to Expand Disease Awareness
- UK Launch Spotlight
- Performance Results
- Alpha Blocker Revenue for Bph Treatment, 1998-2006
- Total Sales of Branded Alpha Blockers for Bph, 1998-2006
- Potential Market Entry Strategies for New Products
- Appendix
- Flomax Profile
- Competitive Landscape at Market Entry
- Key Definitions
- about Best Practices, Llc







